Human Resources
Novo Nordisk leader unpacks the trends set to redefine work: International HR Day

On International HR Day (20 May), Eleanor Clifford, Senior Director of People and Organisation at Novo Nordisk ANZ, offers a grounded perspective on what it means to lead in a world transformed by technology, evolving workplaces, and rising employee expectations.
With the theme of HumanifyAI – Leading Change in a Dynamic World as a backdrop, Clifford explores how Novo Nordisk is embracing artificial intelligence (AI) not as a headline-grabbing innovation but as a tool to enhance performance and productivity, while tackling concerns that often shadow its adoption.
The discussion shifts into the complexities of hybrid work and return-to-office policies, a subject that continues to stir debate across the industry. Clifford cuts through the noise, offering her perspective on what an effective model looks like.
Despite recent backlash to DE&I initiatives globally, Novo Nordisk’s recognition as one of the Best Workplaces for Women serves as a case study in sustained commitment to gender equality, especially in light of upcoming legislation requiring large companies to set and meet gender equality targets.
Looking ahead, Clifford identifies key HR trends that will drive substantial transformations to reshape workplaces and workforces over the next five years.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - MedTech & Diagnostics

Philips remote monitoring cuts hospital costs and ICU time by 69%
An innovative remote patient monitoring model has significantly improved post-operative care for patients, cutting ICU hours by 69% and saving […]
MoreNews - MedTech & Diagnostics

VB Spine breaks ground in ANZ, Takes over Stryker’s spinal implants business
VB Spine has officially taken the reins of Stryker’s spinal implants business in Australia and New Zealand. The transition builds […]
MoreNews - Pharmaceuticals

New therapy PBS listed in advanced Parkinson’s disease
A new therapeutic option for advanced Parkinson’s disease, Vyalev (foslevodopa with foscarbidopa), is now listed on the Pharmaceutical Benefits Scheme […]
MoreNews - Pharmaceuticals

PBS adds first ustekinumab and omalizumab biosimilars in inflammatory and allergic conditions
From 1 August 2025, two new biosimilars – SteQeyma (ustekinumab) and Omlyclo (omalizumab) – have been listed on the Pharmaceutical […]
More